Literature DB >> 27254837

Incidence and mortality of gynaecological cancers: Secular trends in urban Shanghai, China over 40 years.

Zhezhou Huang1, Ying Zheng2, Wanqing Wen3, Chunxiao Wu1, Pingping Bao1, Chunfang Wang4, Weijian Zhong1, Yu-Tang Gao5, Fan Jin5, Yong-Bing Xiang5, Xiao-Ou Shu3, Alicia Beeghly-Fadiel3.   

Abstract

AIM: Appraisal of cancer trends is essential for future cancer control, but relevant studies in China are scarce due to a lack of long-term data. With 40-years of cancer registry data, we sought to evaluate secular time trends in incidence and mortality of gynaecological cancers in an urban Chinese population.
MATERIALS AND METHODS: Data on incidence and mortality of invasive cervical, uterine and ovarian cancer were collected by the Shanghai Cancer Registry. Age-standardised incidence and mortality rates were calculated for women aged 20-84 in urban Shanghai between 1973 and 2012. Age-period-cohort Poisson regression models were used to evaluate age, period and cohort effects. Overall linear trends, interpreted as the estimated annual percentage change (EAPC), were derived from the net drift in age-drift models.
RESULTS: Overall, cervical cancer incidence and mortality substantially decreased (EAPC = -4.5% and -5.5%, respectively); however, an upward trend was apparent among younger women (age <60). Uterine cancer incidence increased slightly (EAPC = 1.8%), while mortality decreased over time (EAPC = -2.4%). Ovarian cancer incidence and mortality both increased, although the increase in incidence (EAPC = 1.8%) was larger than mortality (EAPC = 0.6%). While cohort effects were most evident for cervical cancer incidence and mortality, significant age, period, and cohort effects were found for all three gynaecological cancers evaluated.
CONCLUSIONS: These secular trends in incidence and mortality of gynaecological cancers in Shanghai likely reflect changing risk factor profiles and improved cancer prognosis over time, and suggest new priorities and call for additional efforts for gynaecological cancer prevention and control for women in China.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Gynaecological cancers; Incidence; Mortality; Ovarian cancer; Time trends; Uterine cancer

Mesh:

Year:  2016        PMID: 27254837      PMCID: PMC4942399          DOI: 10.1016/j.ejca.2016.04.016

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  26 in total

1.  Trends in the incidence of uterine cancer in Niigata, Japan: a population-based study from 1982 to 2007.

Authors:  C Banzai; T Yahata; K Tanaka
Journal:  Eur J Gynaecol Oncol       Date:  2011       Impact factor: 0.196

2.  Cancer incidence trends in urban shanghai, 1972-1994: an update.

Authors:  F Jin; S S Devesa; W H Chow; W Zheng; B T Ji; J F Fraumeni; Y T Gao
Journal:  Int J Cancer       Date:  1999-11-12       Impact factor: 7.396

Review 3.  Review of the cervical cancer disease burden in mainland China.

Authors:  Jing Li; Le-Ni Kang; You-Lin Qiao
Journal:  Asian Pac J Cancer Prev       Date:  2011

4.  Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies.

Authors:  Fang-Hui Zhao; Adam K Lewkowitz; Shang-Ying Hu; Feng Chen; Long-Yu Li; Qing-Ming Zhang; Rui-Fang Wu; Chang-Qing Li; Li-Hui Wei; Ai-Di Xu; Wen-Hua Zhang; Qin-Jing Pan; Xun Zhang; Jerome L Belinson; John W Sellors; Jennifer S Smith; You-Lin Qiao; Silvia Franceschi
Journal:  Int J Cancer       Date:  2012-04-24       Impact factor: 7.396

5.  Increased energy intake and a shift towards high-fat, non-staple high-carbohydrate foods amongst China's older adults, 1991-2009.

Authors:  Kelsey Pan; Lindsey P Smith; Carolina Batis; Barry M Popkin; W R Kenan
Journal:  J Aging Res Clin Pract       Date:  2014

6.  Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.

Authors:  Maaike A van der Aa; Eero Pukkala; Jan Willem W Coebergh; Ahti Anttila; Sabine Siesling
Journal:  Int J Cancer       Date:  2008-04-15       Impact factor: 7.396

Review 7.  Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube.

Authors:  Johannes Dietl
Journal:  Arch Gynecol Obstet       Date:  2013-10-08       Impact factor: 2.344

8.  [Trend analysis and prediction of cancer incidence in China].

Authors:  Wan-qing Chen; Rong-shou Zheng; Hong-mei Zeng; Si-wei Zhang; Ni Li; Xiao-nong Zou; Jie He
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2012-07

9.  Temporal trends of main reproductive characteristics in ten urban and rural regions of China: the China Kadoorie biobank study of 300 000 women.

Authors:  Sarah Lewington; LiMing Li; Serini Murugasen; Lai-san Hong; Ling Yang; Yu Guo; Zheng Bian; Rory Collins; Junshi Chen; Hui He; Ming Wu; Tianyou He; Xiaolan Ren; Jinhuai Meng; Richard Peto; Zhengming Chen
Journal:  Int J Epidemiol       Date:  2014-03-17       Impact factor: 7.196

10.  A prospective study of age trends of high-risk human papillomavirus infection in rural China.

Authors:  Le-Ni Kang; Philip E Castle; Fang-Hui Zhao; Jose Jeronimo; Feng Chen; Pooja Bansil; Jing Li; Wen Chen; Xun Zhang; You-Lin Qiao
Journal:  BMC Infect Dis       Date:  2014-02-21       Impact factor: 3.090

View more
  13 in total

1.  Risk factors of perioperative complications and management with enhanced recovery after primary surgery in women with epithelial ovarian carcinoma in a single center.

Authors:  Min Li; Tianjiao Zhang; Jing Zhu; Yuebo Li; Wenying Chen; Yanhu Xie; Wei Zhang; Rongzhu Chen; Wei Wei; Guihong Wang; Jiwei Qin; Weidong Zhao; Dabao Wu; Zhen Shen; Björn Nashan; Ying Zhou
Journal:  Oncol Lett       Date:  2022-03-16       Impact factor: 3.111

Review 2.  Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer.

Authors:  Xianwen Hu; Dandan Li; Yujie Fu; Jiashen Zheng; Zelong Feng; Jiong Cai; Pan Wang
Journal:  Front Oncol       Date:  2022-06-15       Impact factor: 5.738

3.  TNFAIP8 variants as potential epidemiological and predictive biomarkers in ovarian cancer.

Authors:  Hongyu Gao; Zhiran Zhang; Liangliang Jiang; Lei Zhang; Ling Qin; Tianbo Liu; Shanshan Yang
Journal:  Cancer Cell Int       Date:  2020-08-17       Impact factor: 5.722

4.  Low fertility may be a significant determinant of ovarian cancer worldwide: an ecological analysis of cross- sectional data from 182 countries.

Authors:  Wenpeng You; Ian Symonds; Maciej Henneberg
Journal:  J Ovarian Res       Date:  2018-08-16       Impact factor: 4.234

5.  Diagnostic performance of biomarkers for ovarian cancer: Protocol for an overview, evidence mapping, and adjusted indirect comparisons.

Authors:  Jinyong Hua; Jing Liu; Mengge Hua; Runjin Cai; Muyang Li; Jing Wang; Jiancheng Wang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

6.  Adaptation of the Sexuality Scale for Women with Gynecologic Cancer for Turkish Patients.

Authors:  Çigdem Marangoz; Ayten Demir; Eda Özge Yazgan
Journal:  Asia Pac J Oncol Nurs       Date:  2019 Apr-Jun

7.  Ovarian Cancer Incidence in the Multi-Ethnic Asian City-State of Singapore 1968-2012.

Authors:  Jeff Yi-Fu Hwang; Wei-Yen Lim; Chuen Seng Tan; Sheow Lei Lim; John Chia; Khuan Yew Chow; Wen Yee Chay
Journal:  Asian Pac J Cancer Prev       Date:  2019-12-01

8.  Women's cancers in China: a spatio-temporal epidemiology analysis.

Authors:  Rongxin He; Bin Zhu; Jinlin Liu; Ning Zhang; Wei-Hong Zhang; Ying Mao
Journal:  BMC Womens Health       Date:  2021-03-20       Impact factor: 2.809

9.  Cancer mortality trends in an industrial district of Shanghai, China, from 1974 to 2014, and projections to 2029.

Authors:  Mi Li; Shuo Wang; Xue Han; Wenbin Liu; Jiahui Song; Hongwei Zhang; Jia Zhao; Fan Yang; Xiaojie Tan; Xi Chen; Yan Liu; Hui Li; Yibo Ding; Xiaoyu Du; Jianhua Yin; Rong Zhang; Guangwen Cao
Journal:  Oncotarget       Date:  2017-09-30

10.  Transient impact of paclitaxel on mouse fertility and protective effect of gonadotropin‑releasing hormone agonist.

Authors:  Nieying Ma; Ge Chen; Jing Chen; Mengge Cui; Ye Yin; Qiuyue Liao; Minghui Tang; Xue Feng; Xi Li; Sijia Zhang; Ding Ma; Gang Chen; Kezhen Li; Jihui Ai
Journal:  Oncol Rep       Date:  2020-08-19       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.